{
    "nctId": "NCT06123286",
    "briefTitle": "Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms",
    "officialTitle": "An Open Label, Randomized, Waitlist Controlled Trial of Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer, Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Joint Pain",
    "studyType": "INTERVENTIONAL",
    "phase": "EARLY_PHASE1",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "The primary objective is to assess changes in joint function between groups.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer diagnosis (Stage I-III) with any hormonal status.\n* Females aged \u2265 18 years.\n* Currently receiving AI therapy.\n* BMI \u2265 27.\n* Clinical diagnosis of AIMSS.\n* Omega-3 Index \\&lt;8%.\n* Average joint pain score \u2265 4 on the Brief Pain Inventory (BPI) within 7 days of enrollment.\n* Written informed consent obtained from subject and ability and willingness of subject to comply with the requirements of the study.\n\nExclusion Criteria:\n\n* Current use of anticoagulant medications (Including but not limited to Warfarin, Lovenox, Eliquis, Xarelto).\n* Allergy to cherries or fish/fish products.\n* Lifetime history of rheumatoid arthritis and/or inflammatory joint diseases (Including but not limited to reactive arthritis, ankylosing spondylitis, and psoriatic arthritis).\n* Uncontrolled diabetes mellitus as determined by treating physician (with or without the use of glucose lowering medications and/or insulin).\n* Lifetime history of stroke or transient ischemic attacks.\n* New use or dose change of oral or topical analgesics in the previous 14 days. (Including but not limited to opioids, non-steroidal anti-inflammatories, acetaminophen, SNRI's, SSRI's, gabapentinoids, tricyclic antidepressants, and muscle relaxants).\n* Oral or intra-articular steroid use in the previous 30 days (Including but not limited to dexamethasone, prednisone, methylprednisolone, triamcinolone, hydrocortisone).\n* History of joint fracture or surgery of the symptomatic joint in the previous 6 months.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}